[Clinical analysis of 1,142 hospitalized cantonese patients with nasopharyngeal carcinoma]

Ai Zheng. 2006 Feb;25(2):204-8.
[Article in Chinese]

Abstract

Background & objective: Few large-scale epidemiologic investigations of nasopharyngeal carcinoma (NPC) at high incidence region in Guangdong province were reported in recent 20 years. This study was to summarize clinical data of a population of hospitalized Cantonese NPC patients,analyze the epidemiologic characteristics of NPC in the high incidence region, and provide references for the prevention and treatment of NPC.

Methods: Clinical data of 1 142 Cantonese NPC patients, hospitalized in Cancer Center of Sun Yat-sen University between Jan. 1998 and Aug. 2000, were collected according to well-designed forms and statistically analyzed.

Results: The morbidity of NPC in Cantonese showed obvious family clustering: 21.9% of the patients had family history of cancer, and 12.3% had family history of NPC. Moreover, the family clustering feature was more obvious in the population from the region with higher incidence of NPC. The positive rate of VCA/IgA antibody was 90.0%, and that of EA/IgA antibody was 74.5%; the titers were positively related to tumor burden. Early diagnostic rate of NPC was about 30%.

Conclusions: NPC patients in Cantonese population have obvious family and territorial clustering. High positive rates of VCA/IgA and EA/IgA antibodies are helpful for early diagnosis of NPC.

Publication types

  • English Abstract

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, Viral / immunology
  • Capsid Proteins / immunology
  • Carcinoma, Squamous Cell* / epidemiology
  • Carcinoma, Squamous Cell* / genetics
  • Carcinoma, Squamous Cell* / immunology
  • Carcinoma, Squamous Cell* / pathology
  • Child
  • China / epidemiology
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Immunoglobulin A / analysis
  • Male
  • Middle Aged
  • Morbidity
  • Nasopharyngeal Neoplasms* / epidemiology
  • Nasopharyngeal Neoplasms* / genetics
  • Nasopharyngeal Neoplasms* / immunology
  • Nasopharyngeal Neoplasms* / pathology
  • Neoplasm Staging

Substances

  • Antigens, Viral
  • Capsid Proteins
  • Epstein-Barr viral capsid antigen
  • Epstein-Barr virus early antigen
  • Immunoglobulin A